| |
| |
|
| Insider
Information: |
Patel Sanj K |
| Relationship: |
|
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
63,012 |
|
|
Indirect Shares
|
109,795 |
|
|
| Direct
Value |
$1,195,338 |
|
|
|
Indirect Value
|
$2,082,811 |
|
|
| Total
Shares |
172,807 |
|
|
| Total
Value |
$3,278,149 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Synageva BioPharma Corp |
GEVA |
President & CEO, Direc... |
2015-06-22 |
0 |
2015-06-22 |
0 |
Premium* |
|
|
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2024-04-08 |
63,012 |
2024-04-08 |
109,795 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-07-29 |
4 |
OE |
$3.52 |
$55,950 |
D/D |
15,895 |
16,926 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2022-03-21 |
4 |
D |
$10.98 |
$59,797 |
D/D |
(5,446) |
17,756 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2024-04-08 |
4 |
D |
$17.90 |
$72,943 |
D/D |
(4,075) |
63,012 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2023-09-01 |
4 |
D |
$17.76 |
$78,712 |
D/D |
(4,432) |
48,134 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2021-02-08 |
4 |
AS |
$23.00 |
$104,144 |
I/I |
(4,528) |
108,042 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2021-02-08 |
4 |
AS |
$23.00 |
$113,252 |
D/D |
(4,924) |
0 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2024-03-06 |
4 |
AS |
$21.00 |
$117,222 |
I/I |
(5,582) |
65,012 |
0 |
% |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2014-01-28 |
4 |
OE |
$0.95 |
$127,874 |
D/D |
51,329 |
52,360 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-07-26 |
4 |
OE |
$1.70 |
$152,984 |
D/D |
52,190 |
70,425 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2014-01-29 |
4 |
OE |
$3.52 |
$179,418 |
D/D |
50,971 |
52,002 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2020-10-12 |
4 |
OE |
$1.59 |
$239,613 |
D/D |
150,700 |
150,700 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-11-30 |
4 |
AS |
$48.87 |
$244,326 |
D/D |
(5,000) |
1,031 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2024-03-04 |
4 |
AS |
$21.31 |
$273,834 |
I/I |
(12,742) |
70,594 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2021-02-09 |
4 |
AS |
$23.04 |
$470,039 |
D/D |
(20,401) |
0 |
0 |
% |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-04-05 |
4 |
AS |
$50.11 |
$496,590 |
D/D |
(9,910) |
1,031 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2021-02-09 |
4 |
AS |
$23.08 |
$543,973 |
I/I |
(23,569) |
84,473 |
0 |
% |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-12-05 |
4 |
AS |
$48.10 |
$577,255 |
D/D |
(12,000) |
1,031 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-12-14 |
4 |
AS |
$45.30 |
$601,629 |
D/D |
(13,281) |
1,031 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-12-13 |
4 |
AS |
$45.12 |
$657,470 |
D/D |
(14,400) |
1,031 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2020-03-06 |
4 |
AS |
$20.00 |
$662,300 |
I/I |
(33,115) |
212,570 |
0 |
% |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-07-25 |
4 |
AS |
$48.73 |
$716,867 |
D/D |
(14,711) |
18,235 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-07-29 |
4 |
AS |
$47.39 |
$753,264 |
D/D |
(15,895) |
1,031 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-08-31 |
4 |
AS |
$49.88 |
$757,518 |
D/D |
(15,187) |
1,031 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2014-12-17 |
4 |
OE |
$1.70 |
$763,972 |
D/D |
50,000 |
51,031 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-04-03 |
4 |
AS |
$51.09 |
$852,227 |
D/D |
(16,464) |
1,031 |
0 |
- |
|
93 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
